Insider · CIK 0001595117

George Simeon

Reports to the SEC for 13 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001595117

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series B-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.3M sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+513K sh	—	—	4,961,501
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.54M sh	—	—	1,538,691
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+169K sh	—	—	1,836,469
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−601K sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.11M sh	—	—	4,448,604
2026-09-28	ADRXADARx Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+593K sh	$17.00	+$10.1M	592,593
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.8M sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+593K sh	$17.00	+$10.1M	5,554,094
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−1.95M sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+415K sh	$17.00	+$7.05M	1,953,505
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.91M sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.67M sh	—	—	1,667,468
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+3.33M sh	—	—	3,334,938
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series B-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−198K sh	—	—	0
2026-06-10	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37K sh	—	—	37,000
2026-06-09	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2026-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2025-07-16	CRSPCRISPR Therapeutics AGP Purchase	Director	PPurchase	+6,510 sh	$52.03	+$339K	69,687
2025-07-16	CRSPCRISPR Therapeutics AGP Purchase	Director	PPurchase	+22.3K sh	$52.03	+$1.16M	238,897
2025-07-16	CRSPCRISPR Therapeutics AGP Purchase	Director	PPurchase	+961K sh	$52.03	+$50M	1,730,179
2025-06-10	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+19K sh	—	—	19,000
2025-06-05	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2025-06-05	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+46K sh	—	—	46,000
2024-06-13	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2024-06-13	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+19K sh	—	—	19,000
2024-05-30	CRSPCRISPR Therapeutics AG · Stock Option (Right to buy)A Award	Director	AAward	+13K sh	—	—	13,000
2024-03-27	NKTXNkarta, Inc.P Purchase	Director	PPurchase	+452K sh	$10.00	+$4.52M	451,659
2024-03-27	NKTXNkarta, Inc.P Purchase	Director	PPurchase	+1.55M sh	$10.00	+$15.5M	1,548,341
2024-02-27	CRSPCRISPR Therapeutics AGA Award	Director	AAward	+63.2K sh	$71.50	+$4.52M	63,177
2024-02-27	CRSPCRISPR Therapeutics AGA Award	Director	AAward	+217K sh	$71.50	+$15.5M	216,578
2024-02-27	CRSPCRISPR Therapeutics AGA Award	Director	AAward	+769K sh	$71.50	+$55M	769,196
2023-06-08	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2023-06-07	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2023-05-31	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+15K sh	—	—	15,000
2022-12-20	DSGNDesign Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+40K sh	$8.14	+$325K	6,526,476
2022-12-19	DSGNDesign Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+360K sh	$8.63	+$3.11M	6,486,476
2022-12-16	DSGNDesign Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+500K sh	$8.28	+$4.14M	6,126,476
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	—	—	0
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,500 sh	—	—	0
2022-08-17	Turning Point Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2022-08-17	Turning Point Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−2.25M sh	$76.00	−$171M	0
2022-06-15	DSGNDesign Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+15K sh	—	—	15,000
2022-06-09	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+12K sh	—	—	12,000
2022-06-08	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-04-28	NKTXNkarta, Inc.P Purchase	Director	PPurchase	+667K sh	$15.00	+$10M	666,667
2022-04-28	NKTXNkarta, Inc.P Purchase	Director	PPurchase	+667K sh	$15.00	+$10M	666,666
2021-06-13	NKTXNkarta, Inc. · Stock Option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,511
2021-06-10	CRSPCRISPR Therapeutics AG · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-02	Turning Point Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+8,500 sh	—	—	8,500

Recent filings

Accepted (ET)
Sep 294
George Simeon0001193125-26-408061
SEC(opens sec.gov)
Jun 114
George Simeon0001193125-26-267601
SEC(opens sec.gov)
Jun 114
George Simeon0001193125-26-267732
SEC(opens sec.gov)
Jun 94
George Simeon0001193125-26-264390
SEC(opens sec.gov)
Jul 174
George Simeon0000950170-25-096666
SEC(opens sec.gov)

Companies

Address

929 MAIN STREET SUITE 200

REDWOOD CITY, CA, 94063